Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Risk factors for death in patients with beta-thalassemia major: results of a case-control study.

Literature DB >> 16963395

Risk factors for death in patients with beta-thalassemia major: results of a case-control study.

Adriana Ceci, Paola Baiardi, Mariana Catapano, Mariagrazia Felisi, Paolo Cianciulli, Vincenzo De Sanctis, Giovanni Carlo Del Vecchio, Carmelo Magnano, Anna Meo, Aurelio Maggio.

Abstract

This retrospective one to one matched case-control study was aimed at evaluating risk factors for death in beta-thalassemic patients followed in Italian centers between 1997 and 2001. The mortality risk was lower in patients with good compliance to iron chelation therapy and in those treated with deferiprone.

Entities: Chemical Disease Species

Mesh：

Year: 2006 PMID： 16963395

Source DB: PubMed Journal: Haematologica ISSN： 0390-6078 Impact factor: 9.941

Keyword Cloud
Cited

11 in total

1. Deferasirox, deferiprone and desferrioxamine treatment in thalassemia major patients: cardiac iron and function comparison determined by quantitative magnetic resonance imaging.

Authors: Alessia Pepe; Antonella Meloni; Marcello Capra; Paolo Cianciulli; Luciano Prossomariti; Cristina Malaventura; Maria Caterina Putti; Alma Lippi; Maria Antonietta Romeo; Maria Grazia Bisconte; Aldo Filosa; Vincenzo Caruso; Antonella Quarta; Lorella Pitrolo; Massimiliano Missere; Massimo Midiri; Giuseppe Rossi; Vincenzo Positano; Massimo Lombardi; Aurelio Maggio
Journal: Haematologica Date: 2010-09-30 Impact factor: 9.941

Review 2. Optimal management strategies for chronic iron overload.

Authors: James C Barton
Journal: Drugs Date: 2007 Impact factor: 9.546

3. Safety and efficacy of iron chelation therapy with deferiprone in patients with transfusion-dependent thalassemia.

Authors: Saumya S Jamuar; Angeline H M Lai
Journal: Ther Adv Hematol Date: 2012-10

Review 4. Beta-thalassemia.

Authors: Renzo Galanello; Raffaella Origa
Journal: Orphanet J Rare Dis Date: 2010-05-21 Impact factor: 4.123

Risk factors for death in patients with beta-thalassemia major: results of a case-control study.

1. Deferasirox, deferiprone and desferrioxamine treatment in thalassemia major patients: cardiac iron and function comparison determined by quantitative magnetic resonance imaging.

Review 2. Optimal management strategies for chronic iron overload.

3. Safety and efficacy of iron chelation therapy with deferiprone in patients with transfusion-dependent thalassemia.

Review 4. Beta-thalassemia.

Review 5. Deferasirox : a review of its use in the management of transfusional chronic iron overload.

Review 6. Unrelated donor stem cell transplantation for transfusion-dependent thalassemia.

7. The management of iron chelation therapy: preliminary data from a national registry of thalassaemic patients.

8. On improvement in ejection fraction with iron chelation in thalassemia major and the risk of future heart failure.

9. Management of transfusional iron overload - differential properties and efficacy of iron chelating agents.

10. Treating thalassemia major-related iron overload: the role of deferiprone.